Literature DB >> 9406927

Islet amyloid polypeptide and calcitonin gene-related peptide expression are upregulated in lumbar dorsal root ganglia after unilateral adjuvant-induced inflammation in the rat paw.

H Mulder1, Y Zhang, N Danielsen, F Sundler.   

Abstract

After unilateral adjuvant-induced inflammation, expression of neuropeptides believed to be involved in the inflammatory response, e.g. substance P and calcitonin gene-related peptide (CGRP), is upregulated in innervating sensory neurons. Islet amyloid polypeptide (IAPP) is structurally related to CGRP and constitutively expressed in sensory CGRP-containing neurons; the role of IAPP in sensory neurons is unknown. To examine whether IAPP could play a role in inflammation, IAPP expression in L5 dorsal root ganglion (DRG) and its distribution in the dorsal horn were investigated after unilateral adjuvant-induced inflammation in the rat paw and compared with CGRP, using in situ hybridization and immunocytochemistry. At 12 h and day 3, but not day 21, the percentage of nerve cell profiles expressing IAPP and CGRP mRNA was greater in the ipsilateral L5 DRG; these changes paralleled the occurrence of edema around the tarsotibial joint and a slight limp. IAPP expression in individual nerve cell profiles was higher in the ipsilateral L5 DRG at 12 h, but not at days 3 and 21; the corresponding CGRP mRNA level was higher at days 3 and 21. At day 3, the higher expression of IAPP and CGRP on the ipsilateral side was accompanied by increased numbers of immunoreactive DRG neurons and fibers in the spinal cord dorsal horn. Largely, expression of IAPP and CGRP seems to be co-ordinately regulated by localized inflammation, although the rapid, but transient, upregulation in DRG neurons of IAPP mRNA expression and the slower, but sustained, upregulation of CGRP mRNA expression may indicate dissociated regulation of the peptides. Thus, IAPP could play a role in the initial phase of localized inflammation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406927     DOI: 10.1016/s0169-328x(97)00178-2

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  10 in total

Review 1.  Amylin and its G-protein-coupled receptor: A probable pathological process and drug target for Alzheimer's disease.

Authors:  Wei Qiao Qiu
Journal:  Neuroscience       Date:  2017-05-19       Impact factor: 3.590

Review 2.  Pituitary adenylate cyclase-activating polypeptide and islet amyloid polypeptide in primary sensory neurons: functional implications from plasticity in expression on nerve injury and inflammation.

Authors:  H Mulder; H Jongsma; Y Zhang; S Gebre-Medhin; F Sundler; N Danielsen
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

3.  Interaction of amylin with calcitonin gene-related peptide receptors in the microvasculature of the hamster cheek pouch in vivo.

Authors:  J M Hall; S D Brain
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

4.  Secretin mRNA in the subdivision of primary sensory neurons in the trigeminal ganglion of rats.

Authors:  Andrea Heinzlmann; Zsuzsanna E Tóth; Katalin Köves
Journal:  J Mol Neurosci       Date:  2010-06-26       Impact factor: 3.444

5.  Activin acts with nerve growth factor to regulate calcitonin gene-related peptide mRNA in sensory neurons.

Authors:  P Xu; A K Hall
Journal:  Neuroscience       Date:  2007-09-21       Impact factor: 3.590

6.  Activation of extracellular signal-regulated protein kinase 5 is essential for cystitis- and nerve growth factor-induced calcitonin gene-related peptide expression in sensory neurons.

Authors:  Sharon J Yu; Chun-mei Xia; Jarren C Kay; Li-Ya Qiao
Journal:  Mol Pain       Date:  2012-06-28       Impact factor: 3.395

7.  Activin induces tactile allodynia and increases calcitonin gene-related peptide after peripheral inflammation.

Authors:  Pin Xu; Charles Van Slambrouck; Liliana Berti-Mattera; Alison K Hall
Journal:  J Neurosci       Date:  2005-10-05       Impact factor: 6.709

8.  Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?

Authors:  Wei Qiao Qiu; Haihao Zhu
Journal:  Front Aging Neurosci       Date:  2014-07-29       Impact factor: 5.750

Review 9.  Amyloid Proteins and Peripheral Neuropathy.

Authors:  Mohammed M H Asiri; Sjoukje Engelsman; Niels Eijkelkamp; Jo W M Höppener
Journal:  Cells       Date:  2020-06-26       Impact factor: 6.600

Review 10.  Beyond CGRP: The calcitonin peptide family as targets for migraine and pain.

Authors:  Tayla A Rees; Erica R Hendrikse; Debbie L Hay; Christopher S Walker
Journal:  Br J Pharmacol       Date:  2021-07-27       Impact factor: 9.473

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.